Article Versions Notes

Suppan C, Brcic I, Tiran V, Mueller HD, Posch F, Auer M, Ercan E, Ulz P, Cote RJ, Datar RH, et al. Untargeted Assessment of Tumor Fractions in Plasma for Monitoring and Prognostication from Metastatic Breast Cancer Patients Undergoing Systemic Treatment. Cancers. 2019; 11(8):1171. https://doi.org/10.3390/cancers11081171

Suppan, Christoph, Iva Brcic, Verena Tiran, Hannah D Mueller, Florian Posch, Martina Auer, Erkan Ercan, Peter Ulz, Richard J Cote, Ram H Datar, and et al. 2019. "Untargeted Assessment of Tumor Fractions in Plasma for Monitoring and Prognostication from Metastatic Breast Cancer Patients Undergoing Systemic Treatment" Cancers 11, no. 8: 1171. https://doi.org/10.3390/cancers11081171

Suppan, C., Brcic, I., Tiran, V., Mueller, H. D., Posch, F., Auer, M., Ercan, E., Ulz, P., Cote, R. J., Datar, R. H., Dandachi, N., Heitzer, E., & Balic, M. (2019). Untargeted Assessment of Tumor Fractions in Plasma for Monitoring and Prognostication from Metastatic Breast Cancer Patients Undergoing Systemic Treatment. Cancers, 11(8), 1171. https://doi.org/10.3390/cancers11081171